Voloridge Investment Management
STML

Voloridge Investment Management’s Stemline Therapeutics, Inc. STML Stock Holding History

Voloridge Investment Management’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-36,577
Closed -$177K – 1613
2020
Q1 		$177K Buy
+36,577
New +$237K 0.01% 977

Voloridge Investment Management's STML Position: Q2 2020 in Review

Voloridge Investment Management sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 36,577 shares — an estimated $177K sold.

Voloridge Investment Management first reported a position in STML in Q1 2020 and held it in 1 quarter. The position peaked at $177K in Q1 2020. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • Voloridge Investment Management reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Voloridge Investment Management sold 36,577 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $177K.
  • Voloridge Investment Management first reported a position in Stemline Therapeutics, Inc. in Q1 2020 and held it in 1 quarter.
  • Voloridge Investment Management's Stemline Therapeutics, Inc. position peaked at $177K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Voloridge Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.